DOW JONES21,917.16-410.32 -1.84%
S&P 5002,584.59-42.06 -1.60%
NASDAQ7,700.10-74.05 -0.95%
 News
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Business Wire · 4d ago
Xeris Pharma cuts Gvoke copay amid Covid-19
seekingalpha · 5d ago
Xeris Pharmaceuticals Announces $0 Copay for Gvoke PFS for People With Diabetes
Business Wire · 5d ago
Xeris Pharmaceuticals Reinforces the Importance of GVOKE PFS for People With Diabetes
Business Wire · 03/19 13:00
Xeris Pharmaceuticals, Inc. Just Reported Earnings, And Analysts Cut Their Target Price
Simply Wall St. · 03/16 13:10
Xeris Pharmaceuticals, Inc.'s (XERS) CEO Paul Edick on Q4 2019 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 03/11 16:39
Xeris Pharmaceuticals EPS misses by $0.08, beats on revenue
seekingalpha · 03/11 15:04
Xeris Pharmaceuticals, Inc. (XERS) Reports Q4 Loss, Tops Revenue Estimates
Zacks · 03/11 12:30
Xeris Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Highlights Pipeline Progress
Business Wire · 03/11 11:00
Xeris Pharmaceuticals Q4 EPS $(1.23) Misses $(1.13) Estimate, Sales $1.6M Beat $660K Estimate
Benzinga · 03/11 10:02
Earnings Scheduled For March 11, 2020
Benzinga · 03/11 08:28
The Week Ahead In Biotech (March 8-14): Bristol-Myers Awaits FDA Nod For Liver Cancer Combo Therapy, Earnings Flow Continues
Benzinga · 03/08 20:14
The Daily Biotech Pulse: Breakthrough Device Designation For Neuronetics, AbbVie Receives European Label Expansion, AstraZeneca Flunks Late-Stage Study
Benzinga · 03/06 13:49
Analysts Estimate Xeris Pharmaceuticals, Inc. (XERS) to Report a Decline in Earnings: What to Look Out for
Zacks · 03/04 17:30
The Daily Biotech Pulse: Takeda Jumps Into The COVID-19 Fray, Exact Sciences Buys Cancer Diagnostics Companies
Benzinga · 03/04 12:37
Xeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Business Wire · 02/28 21:05
Xeris Pharmaceuticals to Announce Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on March 11, 2020
GlobeNewswire · 02/27 21:05
The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy
Benzinga · 02/27 12:35
Xeris Pharmaceuticals Announces Exercise of Underwriters Option to Purchase Additional Shares
Business Wire · 02/20 21:05
Mizuho Maintains Buy on Xeris Pharmaceuticals, Lowers Price Target to $18
Benzinga · 02/20 12:42